Vitamin D Receptor Upregulation Orchestrates Ferroptosis-Driven Salivary Hyposecretion in Female Sod1 Knockout Mice

Study Background and Research Question

Salivary gland dysfunction and xerostomia (dry mouth) pose significant clinical challenges, particularly among elderly and female populations. While oxidative stress is recognized as a key factor in salivary gland impairment, the molecular mechanisms underlying sex-specific susceptibility remain poorly defined. The recent study by Han et al. (2025) directly addresses this gap by investigating the interplay between superoxide dismutase 1 (Sod1) deficiency, vitamin D receptor (VDR) signaling, and ferroptosis in a murine model. The central question: How does VDR upregulation modulate ferroptosis and salivary secretion in the context of oxidative stress, and why is this effect specific to females?

Key Innovation from the Reference Study

The core innovation of Han et al.'s work lies in connecting VDR-mediated transcriptional regulation to ferroptosis-induced tissue dysfunction within salivary glands. Using Sod1 knockout (SKO) mice to model chronic oxidative stress, the authors demonstrate—uniquely in females—that VDR upregulation directly enhances the expression of transferrin receptor (TFRC), leading to increased iron uptake and activation of ferroptosis pathways. Crucially, this mechanistic axis was shown to drive impaired salivary secretion, establishing a causal link between sex-specific VDR signaling, ferroptotic cell death, and glandular hypofunction. This work is among the first to elucidate how hormone receptor signaling intersects with iron-dependent cell death in a physiologically relevant, sex-dependent context.

Methods and Experimental Design Insights

The research employs a multi-tiered experimental approach:

• In vivo model: Female and male Sod1 knockout (SKO) mice, alongside wild-type controls, were assessed for salivary gland function, gene expression, and markers of oxidative damage.
• Transcriptomic profiling: RNA sequencing of submandibular glands identified differentially expressed genes related to ferroptosis, inflammation, and circadian regulation, with a focus on sex differences.
• Cell culture validation: Human salivary gland epithelial A253 cells were exposed to 4-nitroquinoline N-oxide (4NQO) to induce oxidative stress. The effects of VDR overexpression on ferroptosis-related gene expression and TFRC promoter activity were assessed.
• Biochemical assays: Quantification of reactive oxygen species (ROS), lipid peroxidation products, and salivary output substantiated the link between oxidative stress and glandular dysfunction.

This integrative strategy allowed the authors to dissect both cell-intrinsic and systemic contributions to ferroptosis and hyposecretion.

Core Findings and Why They Matter

Han et al. (2025) report several pivotal findings:

• Female-specific phenotype: Only female SKO mice exhibited pronounced salivary hyposecretion, increased VDR expression, and upregulation of ferroptosis-related genes, despite both sexes experiencing elevated ROS due to Sod1 deficiency.
• VDR as a ferroptosis modulator: In A253 cells, VDR overexpression increased TFRC promoter activity, boosting iron import and sensitizing cells to ferroptosis. This was supported by increased lipid peroxidation and gene signatures of ferroptosis in vivo.
• Pathological cascade: The study mechanistically links VDR upregulation to heightened iron-dependent lipid peroxidation, culminating in ferroptotic cell death and impaired salivary secretion.

These results are notable for illuminating a sex-specific, hormone receptor-driven susceptibility to ferroptotic glandular injury. They also highlight the importance of iron metabolism and the inhibition of lipid peroxidation in salivary tissue protection—advancing our understanding of xerostomia pathogenesis and opening new avenues for intervention.

Comparison with Existing Internal Articles

Several recent reviews and practical guides have positioned ferroptosis inhibitors—such as Liproxstatin-1—as central tools in dissecting iron-dependent cell death and lipid peroxidation pathways. For example, the article "Liproxstatin-1 and the Future of Ferroptosis Research" details how potent inhibitors facilitate mechanistic studies and translational modeling of ferroptosis across various tissues, including GPX4-deficient systems and organ injury models. Likewise, guides such as "Liproxstatin-1 (SKU B4987): Data-Driven Solutions for Ferroptosis Research" provide workflow recommendations for protocol optimization and reproducibility.

The Han et al. study complements these resources by providing a mechanistic, in vivo demonstration of how ferroptosis contributes to salivary gland dysfunction—specifically through the VDR-TFRC axis in the setting of chronic oxidative stress. This work underscores the translational relevance of using potent ferroptosis inhibitors to probe and potentially mitigate tissue-specific injury states, especially those with sex-dependent features.

Limitations and Transferability

The findings of Han et al. (2025) are compelling but carry several limitations that impact generalizability:

• Model specificity: The use of Sod1 knockout mice models a specific form of chronic oxidative stress that may not capture all etiologies of salivary gland dysfunction in humans.
• Sex differences: While the female-specific effects are robust in this model, the extent to which human sex hormones and VDR signaling recapitulate these findings warrants further study.
• Therapeutic translation: The study focuses on mechanistic links; direct evidence for intervention (e.g., with ferroptosis inhibitors) in this model is not provided.

Nevertheless, the clear demonstration that VDR-driven modulation of iron metabolism can precipitate ferroptosis in a tissue- and sex-specific manner provides a valuable framework for future research—including the rational design of ferroptosis-targeted interventions.

Protocol Parameters

• Sod1 knockout model: Use homozygous Sod1-deficient female mice to study the impact of chronic oxidative stress on salivary gland function and ferroptosis susceptibility.
• Oxidative stress induction in vitro: Treat A253 human salivary epithelial cells with 4NQO (10–20 μM for 24–48 h) to mimic ROS elevation and trigger ferroptotic gene signatures.
• VDR overexpression: Transfect cells with VDR-encoding vectors (e.g., pcDNA3.1-VDR) using standard transfection protocols; confirm by qPCR or immunoblotting.
• Assessment of ferroptosis: Quantify lipid peroxidation using BODIPY 581/591 C11 fluorescence; monitor cell viability and iron uptake markers (e.g., TFRC expression) as additional readouts.
• Salivary secretion measurement: In vivo, stimulate mice with pilocarpine (0.5–1 mg/kg, i.p.) and collect saliva for volumetric and biochemical analysis.

Research Support Resources

For researchers seeking to interrogate the role of lipid peroxidation and ferroptotic cell death in salivary gland or other tissue models, potent and selective inhibitors are essential. Liproxstatin-1 (SKU B4987, APExBIO) offers robust inhibition of ferroptosis, with an IC50 of 22 nM and proven efficacy in cell-based and animal models of lipid peroxidation. Practical guidance for integrating this compound into ferroptosis research—including GPX4-deficient and organ injury systems—can be found in scenario-driven reviews such as "Liproxstatin-1 (SKU B4987): Data-Driven Solutions for Ferroptosis Research". When designing protocols to investigate VDR-iron signaling and tissue-specific ferroptosis, Liproxstatin-1 may serve as a valuable tool to dissect causality and screen for protective interventions.